Asian-Oceanian Journal of Pediatrics and Child Health JAPANESE PEDIATRIC BOARD CERTIFICATION: HISTORY AND FUTURE PERSPECTIVES

Size: px
Start display at page:

Download "Asian-Oceanian Journal of Pediatrics and Child Health JAPANESE PEDIATRIC BOARD CERTIFICATION: HISTORY AND FUTURE PERSPECTIVES"

Transcription

1 Asian-Oceanian Journal of Pediatrics and Child Health Volume One December 2002 Number Two JAPANESE PEDIATRIC BOARD CERTIFICATION: HISTORY AND FUTURE PERSPECTIVES Nobutake Matsuo, M.D. (1), John Ichiro Takayama, M.D., M.P.H. (1), Shigehiko Kamoshita, M.D. (2) (1) National Center for Child Health and Development (2) Saniku-kai Hospital Abstract Objectives: The pediatric workforce in the Asia-Oceania region remains unknown. We describe the Japanese Pediatric Board Certification system and recent trends in the Japanese pediatric workforce as defined by board certification. Method: To better define the Japanese pediatric workforce, pediatricians certified by the Japanese Pediatric Board were collectively identified. Characteristics of this workforce and trends between 1994 and 2002 were examined. A telephone survey of a subset of 842 pediatricians who started pediatric residency in 1987 and in 1990 was conducted to determine current work status. Results: 4226 pediatricians received Board Certification in During this period, the number of male pediatricians slightly decreased and that of female pediatricians steadily increased with the total number of pediatricians annually certified slightly increased. Among the subset of 842 pediatricians, 49 (all women) were no longer in practice. Conclusions: If the current trends continue, the cumulative number of Japanese pediatricians is likely to slowly increase in the next decade. Given the age and gender profiles of pediatricians in Japan, however, the current rate of board certification may not be sufficient to maintain a viable workforce. The premature retirement of women pediatricians requires further study. Keywords: Japan, Board Certification, pediatric workforce, women pediatrician.

2 Corresponding author: Nobutake Matsuo, M.D. Address: The National Center for Child Health and Development, Ohkura, Setagaya-ku, Tokyo, Japan Fax: Tel: MEASLES IN HONG KONG 1961 to 2000 Professor Yu-Lung Lau, MD ABSTRACT With the use of measles vaccine since 1967, Hong Kong has experienced a relatively lower incidence of measles until a major outbreak occurred in 1988 with an incidence of 56 per 100,000. Vaccine failures accounted for only 24% of the cases in 1988, therefore control strategies at that time were targeted at increasing the coverage rate rather than introducing a two-dose regimen. After the 1988 measles outbreak, the incidence of measles was only 1.6 per 100,000 for 1989 and A second dose of MMR vaccine was introduced in 1996 because the proportion of measles cases with a history of measles vaccination rose from 16% in 1991 to 43% in An outbreak, mainly because of failure of the first dose to produce immunity, seemed imminent in mid-1997, hence a mass vaccination campaign to vaccinate over one million children aged 1-19 was conducted. After the campaign, the incidence of measles fell to less than 1 per 100,000 between 1998 and A two-dose strategy and supplementary campaign will maintain measles susceptibility at low levels in Hong Kong, hence paving the way for the eradication of measles. Keywords: Measles, Epidemiology, Vaccine Correspondence to: Prof Y.L Lau, Department of Paediatrics & Adolescent Medicine Queen Mary Hospital, Pokfulam Road, Hong Kong PREVALENCE OF MALNUTRITION AMONG CHILDREN IN ASIA Geok Lin Khor Ph.D. * Professor of Community Nutrition, Department of Nutrition & Health Sciences, Faculty of

3 Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia Introduction Significant progress has been made over the last 30 years in the nutritional status of young children. Between 1970 and 2000 the proportion of malnourished children was reduced by 20% in developing countries1. The prevalence of underweight among preschool children (< 5 years old) in developing countries declined from 34.3% in 1985 to 29.3% in In absolute numbers, however the decline is not as impressive. In fact, the number of underweight children has changed little over this period, decreasing from million in 1985 to million in Asia with several highly populated countries bears a vast burden of malnutrition in children. The concentration of malnutrition amongst children is highest in Asia compared with other continents. Seventy percent of the world s malnourished children reside in the region1. About half of the preschool children in Asia are malnourished, ranging from 16% underweight in the People s Republic of China (PRC) to 64% in Bangladesh. Some 120 million children are malnourished, constituting three quarters of the global total. One in three preschool children are stunted, rising to one out of every two children in the countries of South Asia such as India, Bangladesh and Nepal. In terms of number of underweight children, India leads with an estimated 62 million followed by PRC (17 million)3. A high proportion of young children in developing countries suffer from a number of micronutrient deficiencies, besides the problem of protein-energy malnutrition as manifested by underweight and stunting. In the Asia and Pacific region, commonly reported micronutrient problems involving children are iron deficiency anemia, vitamin A deficiency, and iodine deficiency disorders (Table 1). The focus of this report is limited to these major nutritional problems from the perspective of their extent, determinants and consequences on health. Intervention strategies and activities for overcoming malnutrition and specific nutrients are not included as they cover a wide scope and warrant a separate report. LACTOSE INTOLERANCE IN SINGAPORE CHILDREN S.H. Quak, MBBS; M Med (Paediatrics); MD; FRCPCH; FAMS; FRCP (Glasg) ABSTRACT Lactose intolerance is common among Asian children. This paper studies the incidence of lactose intolerance among healthy children in Singapore using oral lactose breath hydrogen test and milk breath hydrogen test. It was found that 74.6% of the children had evidence of lactose intolerance and all the races were similarly affected. There was an increasing incidence with increasing age. Significantly fewer children were symptomatic when milk was used as a source of lactose.

4 Key words: breath test, diarrhoea, abdominal pain, flatulence. Correspondence to: Prof S.H. Quak, Associate Professor, The Children s Medical Institute, National University Hospital, Lower Kent Ridge Road, Singapore PAEDIATRIC AIDS IN ASIA Chitsanu Pancharoen, M.D. Usa Thisyakorn, M.D. Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand, Tel. (662) begin_of_the_skype_highlighting (662) end_of_the_skype_highlighting, Fax (662) Correspondence: Dr. Usa Thisyakorn, Professor of Pediatrics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok Thailand. Abstract The incidence of HIV infection and AIDS amongst children in Asian countries has risen steadily and has become an increasing cause of morbidity and mortality during childhood. More than 90% of all children with HIV infection acquired their infection at birth from HIVinfected mothers. With increasing evidence of heterosexual HIV transmission, the number of infected women and consequently their children is increasing. Transmission rate of HIV from mother to infant varies from 20 to 40 percent in Asian countries, a higher transmission rate was observed when the HIV-infected mothers breast-fed their babies. HIV infection and pediatric AIDS is now threatening much of the progress that has been made in child survival in Asian countries during the past 20 years. Children can be affected directly through HIV infection and AIDS and indirectly by the effects of HIV on their parents which includes orphans, discrimination, infant abandonment and negative impacts on children s education. Another problem of concern is children who are most vulnerable to HIV infection and AIDS and this includes child prostitutes and children in difficult circumstances. Recommendations for action include prevention of parental HIV infection, prevention of motherto-child transmission of HIV, addressing child prostitution, prevention of child labour and

5 improving work conditions, assistance to street children, addressing discrimination, solving the problem of children orphaned by AIDS, reducing HIV-related child abandonment, new roles for schools in reducing impacts. What needs to be done cannot be accomplished by any one agency or group alone. It takes the shared commitment, decision making, resources and efforts of all sectors of society to achieve the goals of protecting children from HIV and its effects. The government, NGOs, businesses and communities including community opinion leaders and most importantly, people living with HIV and AIDS, all have key roles to play in mounting an effective multisectoral response to the problem. It will also require leadership; the cost of indecision and delay in acting will be high. Every additional HIV infection not prevented, every additional child allowed to enter prostitution, every additional child denied an education by discrimination will increase the ultimate economic and social cost to the country. Children are the country s future, the country s response to their problems will give an indication of how highly the country values its future. Keywords: Child HIV infection; child AIDS PREVENTION OF HEPATITIS B VIRUS INFECTION AND ITS RELATED DISEASES BY VACCINATION Mei-Hwei Chang, M.D. Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, TAIWAN Hepatitis B virus (HBV) infection is closely related to chronic liver diseases and hepatocellular carcinoma (HCC). Approximately two billion people in the world have been infected by HBV, and 350 million of them became chronic hepatitis B surface antigen (HBsAg) carriers. The peak age for HCC is between 40 to 60 years in most areas, while the peak age of HCC is younger in Africa. In hyperendemic areas for HBV, most of the complications of chronic HBV infection develop in adulthood,while primary HBV infection occurs mainly during infancy or early childhood [1].

6 HBV infection is prevalent in Asia, Africa, Southern Europe and Latin America, where the HBsAg seropositive rates range from 2 to 20%. In those hyperendemic areas, HBV infections occurs mainly during infancy and early childhood. HCC is an important health problem in those who have been infected early in their lives. Infection during early childhood is a very important event leading to chronicity of the condition and to complications. In Taiwan, the HBsAg carrier rate in the general population is approximately 10 to 20%. Before the implementation of universal HBV vaccination program, the HBsAg seropositive rate was 5% in infants, and increased to 10% at 2 years of age, remaining stationary thereafter[1]. However, the infection rate reflected by anti-hbc seropositivity, reaches 50% by the age of 15 years. This suggests that most chronic HBsAg carriers are infected before 2 years of age in this population [1]. In rural Senegal, by the age of 2 years, 25% of children are infected, while at age 15, the infection rate rises to 80% 2. In hyperendemic areas in Asia, perinatal transmission through HBsAg carrier mothers accounts for 40-50% of HBsAg carriers. Around 90% of the infants of hepatitis B e antigen (HBeAg) seropositive carrier mothers became HBsAg carriers 3, irrespective of a high or low HBsAg carrier rate in the population. Age of infection is an important factor determining the outcome of infection. The other transmission route is horizontal transmission, mainly through highly infectious family members, such as elder siblings, and improperly sterile needles or syringes. Current therapies for hepatitis B, liver cirrhosis and HCC are not satisfactory. Immunoprophylaxis is thus the best way to get rid of the threat of HBV infection and its related HCC. The optimal timing for immunoprophylaxis against HBV infection and its related HCC is during neonatal period or early infancy. Correspondence: Dr Mei-Hwang Chang, No. 7, Chung-Shan S. Road, Department of Pediatrics, National Taiwan University Hospital, Taipei, TAIWAN Telephone No. : (886-2) , ext Fax: (886-2) mhchang@ha.mc.ntu.edu.tw Epidemiology of Kawasaki Disease Hung-Chi Lue, MD, PhD 1, 2, Saji Philip MD1, Hsu Ming-Chia, MD1, Jou-Kou Wang, MD, PhD 2, Mei-Hwan Wu MD, PhD 2. Department of Pediatrics, Min-Sheng General Hospital 1 and National Taiwan University Hospital2, Taiwan Abstract:

7 Objective: To report the epidemiology of Kawasaki disease (KD) based on the Taiwan experiences and a review of the literature. Methods: We conducted four nationwide surveys on the number of patients encountered in hospitals of 100 or more beds with pediatric services in Taiwan. The first survey covered , the second survey , the third survey and the fourth survey The annual incidence of KD was expressed as the number of KD patients per 100,000 children less than 5 years of age. The literature on the incidence of KD was reviewed, compared and discussed. Results: In Taiwan, the first case of KD was encountered in 1976, and the number of patients increased thereafter, to 440 in 1986, 512 in 1993, 736 in 1996, 838 in 1998, and 792 in The incidence increased to 24.8 in 1986, 31.6 in 1993, 46.3 in 1996, then to a peak of 54.3 in Male to female ratio ranged 1.5 to1.7 with an average of 1.6. The percent frequency of patients aged below 2-years ranged 57.6%-65.2%, average 59.8%; 2 to 4-years 23.3%-26.5%, average 25.3% and above 4 years 13.1%-15.8%, average 14.9%. Early coronary artery lesions were present in 27.2% to 31.5%, average 25.9% of the patients. 112 The fatality rate decreased from 0.4% in the first survey to 0.06% in the fourth survey. The peak incidence observed in the past, was the highest, in Japan, second highest 54.3 in Taiwan, followed by 38.9 in Korea, and 32.0 in Hong Kong, China, in the South-East Asian region. In the other regions of the world, the highest was 47.7 in Hawaii, USA, then 20.6 in Ontario, Canada. Conclusions: KD affects mainly infants and children, most frequently in Japan, then in Taiwan, Hawaii, Korea, Hong Kong, Ontario and Beijing. The etiology of KD is still unknown. Key words: Kawasaki disease, coronary artery lesions, epidemiology, Taiwan, the world Corresponding author: Hung-Chi Lue, MD, PhD, FACC Emeritus Professor of Pediatrics, National Taiwan University President, Association of Pediatric Societies of South East Asia Region Director, Min-Sheng General Hospital 168, Ching-Kuo Rd, Tao-Yuan 330, Taiwan Fax: , Tel: begin_of_the_skype_highlighting end_of_the_skype_highlighting hclue@e-ms.com.tw

8 AGE SPECIFIC SEROPREVALENCE OF HEPATITIS A VIRUS INFECTION IN MALAYSIA A CHANGING PATTERN Khairullah N *, Merican I +, Padmanathan A *, Yusup R *, Ismail R # * Malaysian Liver Foundation, + Ministry of Health, # Aventis Pasteur (M) Kuala Lumpur, Malaysia ABSTRACT The change in prevalence of Hepatitis A virus (HAV) infection from hyperendemicity to lower endemicity resulting from improvements in socio-economic status and sanitation has public health implications. The objective of our study is to assess the exposure to HAV in our population in the year 2000 and to determine the epidemiological trend that would contribute to the implementation of preventive measures and control of this disease. We conducted a randomised, cross-sectional survey of 2,200 sera obtained from non-icteric subjects aged 1-70 years for the presence of hepatitis A antibodies. Sera obtained from subjects from Peninsular and East Malaysia were categorised into five regions according to geographical locations. Total antibodies against hepatitis A virus were detected by ELISA using a commercially available kit, ETI-AB-HAVK-3 (DiaSorin, Italy) following the manufacturing s instructions. All statistical tests were two-sided and were interpreted at a 5% level of significance; 95% confidence intervals for prevalence were based on Fleiss quadratic computation. Keywords: Hepatitis A, Seroprevalence, Endemicity, Epidemiological Trend Correspondence to: Raman ISMAIL, MD, MPH, Aventis Pasteur SA, 74, Jalan Universiti, Petaling Jaya, Selangor, Malaysia

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Media centre. WHO Hepatitis B. Key facts.   1 of :12 AM. 1 of 5 2013-08-02 7:12 AM Media centre Hepatitis B Share Print Fact sheet N 204 Updated July 2013 Key facts Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic

More information

Hepatitis B Disease Burden: A Model for Global Estimates and Impact of Vaccination. Susan A. Wang, MD, MPH Division of Viral Hepatitis

Hepatitis B Disease Burden: A Model for Global Estimates and Impact of Vaccination. Susan A. Wang, MD, MPH Division of Viral Hepatitis Hepatitis B Disease Burden: A Model for Global Estimates and Impact of Vaccination Susan A. Wang, MD, MPH Division of Viral Hepatitis Barriers to Appreciating HBV Disease Burden and Vaccine Impact Chronic

More information

Ms. Gaye Phillips, Representative, UNICEF Malaysia, Mr. Kiyoshi Nakamitsu, Programme Officer, UNICEF Malaysia, Distinguished Guests,

Ms. Gaye Phillips, Representative, UNICEF Malaysia, Mr. Kiyoshi Nakamitsu, Programme Officer, UNICEF Malaysia, Distinguished Guests, SPEECH BY YB DATO DR. CHUA SOI LEK, MINISTER OF HEALTH MALAYSIA, AT THE ANNOUNCEMENT OF THE PROGRESS FOR CHILDREN GLOBAL REPORT, AT WISMA UN, DAMANSARA HEIGHTS, KUALA LUMPUR, ON 18 NOV 2004 AT 10.30 AM

More information

Viral Hepatitis in Reproductive Health

Viral Hepatitis in Reproductive Health Viral Hepatitis in Reproductive Health Training Course in Sexual and Reproductive Health Research Geneva 2010 Dr José M Bengoa Dr Pierre Jean Malè Consultants Division of Gastroenterology and Hepatology

More information

HEPATITIS B VACCINATION IN TAIWAN AND THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHILDREN

HEPATITIS B VACCINATION IN TAIWAN AND THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHILDREN UNIVERSAL HEPATITIS B VACCINATION IN TAIWAN AND THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHILDREN MEI-HWEI CHANG, M.D., CHIEN-JEN CHEN, SC.D., MEI-SHU LAI, M.D., HSU-MEI HSU, M.P.H., TZEE-CHUNG WU,

More information

Hepatitis B virus (HBV) infection is an important. Brief Communication

Hepatitis B virus (HBV) infection is an important. Brief Communication Brief Communication Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination Yen-Hsuan Ni, MD, PhD; Mei-Hwei Chang, MD; Li-Min Huang,

More information

Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific

Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific Augustina Manuzak, MD, MPH, PhD Augustina.manuzak@doh.hawaii.gov 10/10/2012

More information

JMSCR Volume 03 Issue 01 Page January 2015

JMSCR Volume 03 Issue 01 Page January 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Seroprevalence of HBV among HIV Patients and Blood Donors Author Dr. Vedavati B I 1, Dr. Amrutha Kumari B 2, Dr. Venkatesha D 3 Mysore

More information

EVALUATION OF THE SCHOOL-BASED HEPATITIS B VACCINATION PROGRAMME IN CATALONIA (SPAIN)

EVALUATION OF THE SCHOOL-BASED HEPATITIS B VACCINATION PROGRAMME IN CATALONIA (SPAIN) EVALUATION OF THE SCHOOL-BASED HEPATITIS B VACCINATION PROGRAMME IN CATALONIA (SPAIN) Prof. L. Salleras Department of Public Health University of Barcelona Hospital Clínic Barcelona Hepatitis B vaccine:

More information

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL The World Health Organisation recent initiatives on HBV infection Launching of the

More information

Viral Hepatitis B and C in North African Countries

Viral Hepatitis B and C in North African Countries Viral Hepatitis B and C in North African Countries Prevalence, Risk factors and How to prevent Prof. Ossama Rasslan President, ESIC ICAN, Vice-Chair ICAN 2014, Harare, Zimbabwe, Nov 3rd 5th Overview Viral

More information

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017 Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen

More information

SEROPREVALENCE OF HEPATITIS B AND C VIRUS INFECTIONS AMONG LAO BLOOD DONORS

SEROPREVALENCE OF HEPATITIS B AND C VIRUS INFECTIONS AMONG LAO BLOOD DONORS SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH SEROPREVALENCE OF HEPATITIS B AND C VIRUS INFECTIONS AMONG LAO BLOOD DONORS Prapan Jutavijittum 1, Amnat Yousukh 1, Bounthome Samountry 2, Khamtim Samountry 2,

More information

HBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board

HBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board HBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board 2 nd Hepatitis Cure and Eradication Meeting 11 12 November 2015 Declaration of Interest

More information

The Hepatitis B Vaccine: What Went Wrong?

The Hepatitis B Vaccine: What Went Wrong? The Hepatitis B Vaccine: What Went Wrong? By F. Edward Yazbak, MD, FAAP On Dec. 23, 2005, the Centers for Disease Control and Prevention (CDC) published a Morbidity and Mortality Weekly Report (1) in which

More information

GLOBAL HIV STATISTICS

GLOBAL HIV STATISTICS F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were

More information

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver

More information

MALNUTRITION. At the end of the lecture students should be able to:

MALNUTRITION. At the end of the lecture students should be able to: MALNUTRITION 1 MALNUTRITION OBJECTIVES: At the end of the lecture students should be able to: Define and classify malnutrition Enumerate causes and effects of malnutrition Identify strategies for prevention

More information

EAST LONDON INTEGRATED CARE

EAST LONDON INTEGRATED CARE CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver

More information

Part I. Health-related Millennium Development Goals

Part I. Health-related Millennium Development Goals 11 1111111111111111111111111 111111111111111111111111111111 1111111111111111111111111 1111111111111111111111111111111 111111111111111111111111111111 1111111111111111111111111111111 213 Part I Health-related

More information

Balance Sheets 1. CHILD HEALTH... PAGE NUTRITION... PAGE WOMEN S HEALTH... PAGE WATER AND ENVIRONMENTAL SANITATION...

Balance Sheets 1. CHILD HEALTH... PAGE NUTRITION... PAGE WOMEN S HEALTH... PAGE WATER AND ENVIRONMENTAL SANITATION... Balance Sheets A summary of the goals, gains and unfinished business of the 1990-2000 decade as included in the Report of the Secretary-General, 'We the Children: End-decade review of the follow-up to

More information

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis

More information

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort: International PolioPlus Committee PolioPlus Facts and Figures June 2018 1. The goal of the PolioPlus program: The goal of the PolioPlus program is the global certification of polio eradication. By eradication,

More information

HBV in New Zealand Community HBV screening to long-term follow-up

HBV in New Zealand Community HBV screening to long-term follow-up HBsAg+ icteric hepatitis (n) % anti-hbcore+ 26/9/214 HBV in New Zealand Community HBV screening to long-term follow-up John Hornell, CEO, A registered charitable trust whose mission is: To improve health

More information

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme Global Reporting System for Hepatitis (GRSH) An introduction WHO Global Hepatitis Programme 2018 Objectives 1. Explain the role of the new reporting system 2. Outline the reporting required from countries

More information

Global Epidemiology and Prevention of Hepatitis B

Global Epidemiology and Prevention of Hepatitis B Global Epidemiology and Prevention of Hepatitis B Dr. Steven Wiersma WHO Geneva Strengthening immunisation systems and introduction of hepatitis B vaccine in Central and Eastern Europe and the Newly Independent

More information

Hepatitis B: A Silent Epidemic for Asian-Americans

Hepatitis B: A Silent Epidemic for Asian-Americans Fiona Hinze HumBio 122M June 6, 2012 Hepatitis B: A Silent Epidemic for Asian-Americans The Issue Hepatitis B is a viral disease that causes 80% of liver cancers (hepatocellular carcinoma). Hepatitis B

More information

aids in asia and the pacific

aids in asia and the pacific HIV AIDS AND DEVELOPMENT IN ASIA AND THE PACIFIC a lengthening shadow aids in asia and the pacific World Health Organization Regional Offices for South East Asia and the Western Pacific Region 9 10 OCTOBER

More information

Update on the nutrition situation in the Asia Pacific region

Update on the nutrition situation in the Asia Pacific region Update on the nutrition situation in the Asia Pacific region Mike Toole 13 th National Rural Health Conference, Darwin, 24-27 May 2015 Source: DFAT, Port Moresby, Papua New Guinea Conceptual framework

More information

Chapter 2 Hepatitis B Overview

Chapter 2 Hepatitis B Overview Chapter 2 Hepatitis B Overview 23 24 This page intentionally left blank. HEPATITIS B OVERVIEW Hepatitis B Virus The hepatitis B virus (HBV) belongs to the Hepadnaviridae family and is known to cause both

More information

Global Consultation on Child and Adolescent Health and Development 13 March 2002 Stockholm, Sweden

Global Consultation on Child and Adolescent Health and Development 13 March 2002 Stockholm, Sweden Global Consultation on Child and Adolescent Health and Development 12-13 13 March 2002 Stockholm, Sweden Mdm. Bruntland Says: 11 million children die each year 8 million can be averted each year Each decade

More information

Selected vaccine introduction status into routine immunization

Selected vaccine introduction status into routine immunization Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF

More information

UNIVERSITY OF CALGARY. Trends in Hepatocellular Carcinoma Incidence and Mortality in Canada from through Gaia Pocobelli A THESIS

UNIVERSITY OF CALGARY. Trends in Hepatocellular Carcinoma Incidence and Mortality in Canada from through Gaia Pocobelli A THESIS UNIVERSITY OF CALGARY Trends in Hepatocellular Carcinoma Incidence and Mortality in Canada from 1976 through 2000. by Gaia Pocobelli A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT

More information

Monitoring the achievement of the health-related Millennium Development Goals

Monitoring the achievement of the health-related Millennium Development Goals SIXTY-SIXTH WORLD HEALTH ASSEMBLY A66/13 Provisional agenda item 14.1 14 May 2013 Monitoring the achievement of the health-related Millennium Development Goals Report by the Secretariat 1. In response

More information

THAILAND THAILAND 207

THAILAND THAILAND 207 THAILAND 27 List of Country Indicators Selected Demographic Indicators Selected demographic indicators Child Mortality and Nutritional Status Trends in neonatal, infant and child mortality rates Distribution

More information

Increase Hepatitis B Screening and Vaccinations

Increase Hepatitis B Screening and Vaccinations 17 Increase Hepatitis B Screening and Vaccinations Situation Viral hepatitis is considered to be the most common contagious disease in Japan. Of the estimated three million patients and carriers of viral

More information

Evidence of protection against clinical and chronic hepatitis B infection 20 year after infant vaccination in Thailand

Evidence of protection against clinical and chronic hepatitis B infection 20 year after infant vaccination in Thailand Evidence of protection against clinical and chronic hepatitis B infection 20 year after infant vaccination in Thailand http://waipra.blogspot.com/2011/02/9.html Burden of disease in Thailand Liver diseases

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

Epidemiology of Hepatitis B in sub-saharan Africa. 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur

Epidemiology of Hepatitis B in sub-saharan Africa. 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur Epidemiology of Hepatitis B in sub-saharan Africa 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur From the Big Three to the Big Four 1600000 Number of deaths/year 1400000 HAV + HEV 1200000 1000000

More information

Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants

Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants ORIGINAL ARTICLE Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants Chien-Hung Chen, 1 Pei-Ming Yang, 1

More information

Notes Setting the Scene

Notes Setting the Scene We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping

More information

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura July 2008 Ministry of Foreign Affairs of Japan Background Address by Foreign Minister Koumura Global Health and Japan s Foreign Policy From Okinawa to Toyako (25 November 2007) Special Address by Prime

More information

We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles

We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles 0 We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping

More information

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of

More information

HEPATITIS B ELIMINATION IN ALASKA Lisa Townshend-Bulson, RN, MSN, FNP-C Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium

HEPATITIS B ELIMINATION IN ALASKA Lisa Townshend-Bulson, RN, MSN, FNP-C Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium HEPATITIS B ELIMINATION IN ALASKA Lisa Townshend-Bulson, RN, MSN, FNP-C Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium Anchorage, Alaska USA Goals of My Lecture Highlight the

More information

Steps toward Measles Eradication in Japan A report from Okinawa Prefecture

Steps toward Measles Eradication in Japan A report from Okinawa Prefecture Conferences and Lectures Steps toward Measles Eradication in Japan A report from Okinawa Prefecture JMAJ 53(1): 19 23, 2010 Kaoru ASHIMINE* 1 Okinawa, a Measles-endemic Prefecture in Japan In 1998 1999,

More information

Bangladesh Resource Mobilization and Sustainability in the HNP Sector

Bangladesh Resource Mobilization and Sustainability in the HNP Sector Bangladesh Resource Mobilization and Sustainability in the HNP Sector Presented by Dr. Khandakar Mosharraf Hossain Minister for Health and Family Welfare Government of the People's Republic of Bangladesh

More information

AN ECONOMIC EVALUATION OF UNIVERSAL INFANT VACCINATION STRATEGIES AGAINST HEPATITIS B IN THAILAND: AN ANALYTIC DECISION APPROACH TO COST-EFFECTIVENESS

AN ECONOMIC EVALUATION OF UNIVERSAL INFANT VACCINATION STRATEGIES AGAINST HEPATITIS B IN THAILAND: AN ANALYTIC DECISION APPROACH TO COST-EFFECTIVENESS AN ECONOMIC EVALUATION OF UNIVERSAL INFANT VACCINATION STRATEGIES AGAINST HEPATITIS B IN THAILAND: AN ANALYTIC DECISION APPROACH TO COST-EFFECTIVENESS Thosporn Vimolket 1 and Yong Poovorawan 2 1 Department

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.

More information

State of the Network. TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008

State of the Network. TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008 State of the Network TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008 Research Community Education TAHOD Program Update Current recruitment of ~4,000 patients from 17 sites in 12 countries

More information

HBV-2 Group: neonates born to HBsAg+ and HBeAg+ mothers who received a 4-dose vaccination regimen (Part of

HBV-2 Group: neonates born to HBsAg+ and HBeAg+ mothers who received a 4-dose vaccination regimen (Part of The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Critical immunity thresholds for measles elimination

Critical immunity thresholds for measles elimination Critical immunity thresholds for measles elimination Sebastian Funk Centre for the Mathematical Modelling of Infectious Diseases London School of Hygiene & Tropical Medicine 19 October, 2017!"vöå"!(}å!öZ&!

More information

COUNTRY STATEMENT (MALAYSIA)

COUNTRY STATEMENT (MALAYSIA) COUNTRY STATEMENT (MALAYSIA) By The Hon. Datuk Hajah Azizah binti Datuk Seri Panglima Mohd. Dun, Deputy Minister, Women, Family and Community Development, Malaysia 19 20 September 2013 Sixth Asian and

More information

Viral Hepatitis in Ireland, 2005

Viral Hepatitis in Ireland, 2005 Viral Hepatitis in Ireland, 25 Key Points Hepatitis A incidence remained low, with 56 cases notified in 25 The number of hepatitis B notifications continued to increase with 95 cases reported in 25, compared

More information

Improving HIV/AIDS management in children:nutrition as a vital component

Improving HIV/AIDS management in children:nutrition as a vital component Prof Isaac K. Quay University of Botswana School of Medicine (codata:24-27 th Oct) Improving HIV/AIDS management in children:nutrition as a vital component Isaac K. Quaye, University of Botswana School

More information

CHILD HEALTH. There is a list of references at the end where you can find more information. FACT SHEETS

CHILD HEALTH. There is a list of references at the end where you can find more information. FACT SHEETS SOME 18,000 CHILDREN STILL DIE EVERY DAY FROM DISEASES THAT ARE MOSTLY PREVENTABLE. This fact sheet outlines some of the basic information related to the health and wellbeing of children under five years

More information

Nutrition Profile of the WHO South-East Asia Region

Nutrition Profile of the WHO South-East Asia Region Nutrition Profile of the WHO South-East Asia Region Table of Contents iii Foreword v WHO Vision and Mandate* Department of Nutrition for Health and Development VISION vi MANDATE vii WHO South-East Asia

More information

Ex Post-Evaluation Brief India: Polio Immunisation Programme, Phases I to VII

Ex Post-Evaluation Brief India: Polio Immunisation Programme, Phases I to VII Ex Post-Evaluation Brief India: Polio Immunisation Programme, Phases I to VII Polio Immunisation Programme Phases I VII (1996 Programme/Client 66 140; 1999 65 906; 2000 65 581; 2002 66 213; 2002 66 858;

More information

Summary of Seroprotection after Recombinant Hepatitis B Vaccine Administered to Newborn Infants (defined as the first 30 days of Life) Background:

Summary of Seroprotection after Recombinant Hepatitis B Vaccine Administered to Newborn Infants (defined as the first 30 days of Life) Background: Prepared by: TV Murphy, MD, September 16, 2016 Summary of Seroprotection after Recombinant Hepatitis B Vaccine Administered to Newborn Infants (defined as the first 30 days of Life) Background: The primary

More information

PERINATAL HEPATITIS B

PERINATAL HEPATITIS B PERINATAL HEPATITIS B A Prevention Strategy Douglas County Health Department, Omaha, NE Why Prevention is Important About 1.25 million people in the U.S. have chronic hepatitis B infection Hepatitis B

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

Hepatitis B vaccination worldwide: Lessons learnt and the way forward

Hepatitis B vaccination worldwide: Lessons learnt and the way forward Hepatitis B vaccination worldwide: Lessons learnt and the way forward VHPB Russia meeting Oct 2018 Pierre Van Damme MD, PhD History Hepatitis B vaccines have been available since early 1980 s First recommended

More information

Hepatitis B surface antigen HBsAg Hepatitis B e antigen HBeAg 1) B

Hepatitis B surface antigen HBsAg Hepatitis B e antigen HBeAg 1) B 292 14 4 B Effects of the Vaccination Against Hepatitis B Virus for All Infants in Taiwan Chang-Kuen Tien, Nobutaka Kurihara, Hiroyuki Yanagisawa and Osamu Wada (Hygiene and Preventive Medicine, Saitama

More information

Hepatitis B from targeted screening and immunisation of migrant mothers to universal immunisation in Australia

Hepatitis B from targeted screening and immunisation of migrant mothers to universal immunisation in Australia Hepatitis B from targeted screening and immunisation of migrant mothers to universal immunisation in Australia Tilman Ruff Nossal Institute for Global Health, University of Melbourne Consultant: Australian

More information

The Development of Rehabilitation Services in the Australasian Region

The Development of Rehabilitation Services in the Australasian Region The Development of Rehabilitation Services in the Australasian Region John OLVER AM MBBS MD FAFRM (RACP) Director Rehabilitation Epworth Healthcare Professor Rehabilitation Medicine Department of Medicine

More information

GLOBAL STATISTICS FACT SHEET 2015

GLOBAL STATISTICS FACT SHEET 2015 FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with

More information

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine The Burden of Heart Failure in the Asia Pacific Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine Q1. The most prevalent risk factor for heart failure in the

More information

Children infected with HIV

Children infected with HIV This Section describes the impact of HIV and AIDS on young children and the extent of the problem. It also provides an overview of how HIV is transmitted to infants and young children. HIV and AIDS can

More information

Jose D Sollano, MD Professor of Medicine University of Santo Tomas Manila, Philippines. University of Santo Tomas

Jose D Sollano, MD Professor of Medicine University of Santo Tomas Manila, Philippines. University of Santo Tomas Jose D Sollano, MD Professor of Medicine Manila, Philippines International Variation in Age-Standardized Liver Cancer Incidence Rates in Both Sexes, 2008 Global Age-Standardized Liver Cancer Incidence

More information

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature Hepatitis B Epidemic jaundice described by Hippocrates in 5th century BC Jaundice reported among recipients of human serum and yellow fever vaccines in 1930s and 1940s Australia antigen described in 1965

More information

IMPROVING NUTRITION SECURITY IN ASIA An EU-UNICEF Joint Action

IMPROVING NUTRITION SECURITY IN ASIA An EU-UNICEF Joint Action IMPROVING NUTRITION SECURITY IN ASIA An EU-UNICEF Joint Action One billion people in the world suffer from chronic hunger. Two thirds of them live in Asia. This is a crisis with devastating and farreaching

More information

SEROLOGICAL SURVEY OF VIRAL HEPATITIS A, B, AND C AT THAI CENTRAL REGION AND BANGKOK: A POPULATION BASE STUDY

SEROLOGICAL SURVEY OF VIRAL HEPATITIS A, B, AND C AT THAI CENTRAL REGION AND BANGKOK: A POPULATION BASE STUDY SEROLOGICAL SURVEY OF VIRAL HEPATITIS A, B, AND C AT THAI CENTRAL REGION AND BANGKOK: A POPULATION BASE STUDY Winai Ratanasuwan 1, Areeua Sonji 1, Surapee Tiengrim 2, Wichai Techasathit 1 and Surapol Suwanagool

More information

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study ARTICLE Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study Mei-Hwei Chang, San-Lin You, Chien-Jen Chen, Chun-Jen Liu, Chuan-Mo Lee, Shi-Ming Lin, Heng-Cheng

More information

Multi Sectoral Nutrition Strategy Anne M. Peniston, Chief, Nutrition Division, GH/HIDN, USAID

Multi Sectoral Nutrition Strategy Anne M. Peniston, Chief, Nutrition Division, GH/HIDN, USAID Multi Sectoral Nutrition Strategy 2014 2025 Anne M. Peniston, Chief, Nutrition Division, GH/HIDN, USAID Session Objectives Participants will be able to: Demonstrate an understanding of the background and

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

FACTS FIGURES A FUTURE

FACTS FIGURES A FUTURE International Agency for Research on Cancer, 2012 Let s face the ACTS GLOBAL INITIATIVE FOR CANCER REGISTRY DEVELOPMENT INITIATIVE MONDIALE POUR LE DEVELOPPEMENT DES REGISTRES DU CANCER INICIATIVA MUNDIAL

More information

Reducing Malnutrition in Zambia: Summary of Estimates to Support Nutrition Advocacy ZAMBIA NUTRITION PROFILES 2017

Reducing Malnutrition in Zambia: Summary of Estimates to Support Nutrition Advocacy ZAMBIA NUTRITION PROFILES 2017 Reducing Malnutrition in Zambia: Summary of Estimates to Support Nutrition Advocacy ZAMBIA NUTRITION PROFILES 2017 This report is made possible by the generous support of the American people through the

More information

CANSA DETECTIVES. The very real prospect of eradicating liver cancer in southern Africa

CANSA DETECTIVES. The very real prospect of eradicating liver cancer in southern Africa CANSA DETECTIVES The very real prospect of eradicating liver cancer in southern Africa CANSA Head Office PO Box 2121 Bedfordview 2008 Tel: 27 11 616 7662 Fax: 27 11 622 3424 e-mail: research@cansa.org.za

More information

Early Nutrition and Adult Noncommunicable. that must be broken

Early Nutrition and Adult Noncommunicable. that must be broken Early Nutrition and Adult Noncommunicable diseases: A vital link that must be broken Commonwealth Health Ministers Meeting WHO, Geneva May 14, 2011 Anna Lartey (Associate Professor) Department of Nutrition

More information

Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida

Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries

More information

Actions Sub-actions Evidence Category * 2e. Nutrition-related illness and disease prevention and management among pregnant and postpartum women

Actions Sub-actions Evidence Category * 2e. Nutrition-related illness and disease prevention and management among pregnant and postpartum women ANNEX 3 HEALTH: SUMMARY LIST OF ACTIONS AND SUB-ACTIONS Nutrition Interventions Delivered through Reproductive and Paediatric Health Services Evidence Category * 1. Family planning support for optimal

More information

The Paradox of Malnutrition in Developing Countries (Pp.40-48)

The Paradox of Malnutrition in Developing Countries (Pp.40-48) An International Multi-Disciplinary Journal, Ethiopia Vol. 5 (2), Serial No. 19, April, 2011 ISSN 1994-9057 (Print) ISSN 2070-0083 (Online) The Paradox of Malnutrition in Developing Countries (Pp.40-48)

More information

Insights into Child Nutritional Status and Programmes in Malaysia

Insights into Child Nutritional Status and Programmes in Malaysia Insights into Child Nutritional Status and Programmes in Malaysia Khor Geok Lin International Medical University, Malaysia Kuala Lumpur 6-7 Nov 2012 1 Child nutritional status in Malaysia including changing

More information

LAUNCH OF SOUTH ASIA HUMAN DEVELOPMENT REPORT Rima Salah, Deputy Executive Director, UNICEF UNICEF House 27 July 2005

LAUNCH OF SOUTH ASIA HUMAN DEVELOPMENT REPORT Rima Salah, Deputy Executive Director, UNICEF UNICEF House 27 July 2005 LAUNCH OF SOUTH ASIA HUMAN DEVELOPMENT REPORT Rima Salah, Deputy Executive Director, UNICEF UNICEF House 27 July 2005 Excellencies, distinguished guests, ladies and gentlemen. On behalf of UNICEF, let

More information

Hepatitis B. Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre

Hepatitis B. Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre Hepatitis B Introduction Hepatitis B virus is one of the most prevalent viruses worldwide and is a major cause of chronic liver disease and hepatocellular carcinoma. It is a hepadnavirus, consisting of

More information

Incomplete Hepatitis B Immunization, Maternal Carrier Status, and Increased Risk of Liver Diseases: A 20-Year Cohort Study of 3.8 Million Vaccinees

Incomplete Hepatitis B Immunization, Maternal Carrier Status, and Increased Risk of Liver Diseases: A 20-Year Cohort Study of 3.8 Million Vaccinees Incomplete Hepatitis B Immunization, Maternal Carrier Status, and Increased Risk of Liver Diseases: A 20-Year Cohort Study of 3.8 Million Vaccinees Yin-Chu Chien, 1 Chyi-Feng Jan, 2 Chun-Ju Chiang, 3 Hsu-Sung

More information

Together, hidden hunger. THE SOLUTIONS ARE IN OUR HANDS. Micronutrient Initiative. we can end

Together, hidden hunger. THE SOLUTIONS ARE IN OUR HANDS. Micronutrient Initiative. we can end Together, we can end hidden hunger. THE SOLUTIONS ARE IN OUR HANDS. Micronutrient Initiative Micronutrient Initiative The Micronutrient Initiative (MI) is the leading organization working exclusively to

More information

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.

More information

HEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011

HEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B INFECTION and Pregnancy Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B 26/07/2011 What is Hepatitis B? It is inflammation (infection) of the liver

More information

CANSA DETECTIVES. The very real prospect of eradicating liver cancer in southern Africa. Cancer affects us all...

CANSA DETECTIVES. The very real prospect of eradicating liver cancer in southern Africa. Cancer affects us all... CANSA DETECTIVES The very real prospect of eradicating liver cancer in southern Africa CANCER DETECTIVES Booklet 1 The very real prospect of eradicating liver cancer in southern Africa What intrigued Dr

More information

OB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program

OB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program OB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program Dear Colleague, This letter is to introduce myself and explain the role I play with the Alaska Perinatal Hepatitis B Program. Alaska

More information

Country Analyst. Asia: Swine Flu and the 2003 SARS Experience

Country Analyst. Asia: Swine Flu and the 2003 SARS Experience Suan Teck Kin, CFA Suan.TeckKin@uobgroup.com Jimmy Koh Jimmy.KohCT@uobgroup.com UOB Economic-Treasury Research Company Reg No. 193500026Z Asia: Swine Flu and the 2003 SARS Experience The current outbreak

More information

Global reductions in measles mortality and the risk of measles resurgence

Global reductions in measles mortality and the risk of measles resurgence Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there

More information

Lifetime risk of infection >60% Early childhood infections common

Lifetime risk of infection >60% Early childhood infections common Hepatitis Community Medicine HBV Public health sig HBV is 100 times more infectious than HIV. >350 million chronically infected worldwide. >1 million people die annually of HBV- related chronic liver disease.

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),

More information

Child mortality in ACP countries: getting to zero? Simon Wright President, Global Health Advocates

Child mortality in ACP countries: getting to zero? Simon Wright President, Global Health Advocates Child mortality in ACP countries: getting to zero? Simon Wright President, Global Health Advocates Latest estimates Substan(al progress made towards achieving MDG 4. 12.6 million in 1990 to 6.6 million

More information

How does HBV affect the liver?

How does HBV affect the liver? Hepatitis B Why is the liver important? Your liver is a vital organ that performs many essential functions. It s the largest solid organ in the body and is located under your rib cage on the upper right

More information

Technical matters: Viral hepatitis

Technical matters: Viral hepatitis REGIONAL COMMITTEE Provisional Agenda item 8.6 Sixty-seventh Session SEA/RC67/29 Dhaka, Bangladesh 9 12 September 2014 28 July 2014 Technical matters: Viral hepatitis Viral hepatitis is a serious public

More information